TR
Third Rock Ventures II, L.P. Other
US US · SEC (Form 4)
Explore the full record of transactions filed by Third Rock Ventures II, L.P.. Officer active across 2 companies, notably Revolution Medicines, Inc.. Cumulatively, 19 filings have been recorded. Total volume traded: €68.6m. The latest transaction was filed on 8 June 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 19 total
€8m 419,901 shares @ €18.8941 100.0% of flow
Common Stock
SEC:0000899243-22-022013:0 · 8 Jun 2022
€14m 1,900,000 shares @ €7.3183 50.0% of flow
Common Stock
SEC:0000899243-21-044916:0 · 12 Nov 2021
€14m 1,900,000 shares @ €7.3183 100.0% of flow
Common Stock
SEC:0000899243-21-044916 · 12 Nov 2021
1,000,000 shares
Common Stock
SEC:0000899243-21-044424 · 10 Nov 2021
1,000,000 shares
Common Stock
SEC:0000899243-21-044424:0 · 10 Nov 2021
1,000,000 shares
Common Stock
SEC:0000899243-21-037614 · 22 Sept 2021
1,000,000 shares
Common Stock
SEC:0000899243-21-037614:0 · 22 Sept 2021
1,750,000 shares
Common Stock
SEC:0000899243-21-036411:0 · 15 Sept 2021
1,750,000 shares
Common Stock
SEC:0000899243-21-036411 · 15 Sept 2021
1,500,000 shares
Common Stock
SEC:0000899243-21-023555 · 10 Jun 2021
1,500,000 shares
Common Stock
SEC:0000899243-21-023555:0 · 10 Jun 2021
€9m 378,117 shares @ €24.8908 36.7% of flow
Common Stock
SEC:0000899243-21-022345:0 · 3 Jun 2021
€9m 378,117 shares @ €24.8908 73.4% of flow
Common Stock
SEC:0000899243-21-022345 · 3 Jun 2021
€3m 135,000 shares @ €25.2508 13.3% of flow
Common Stock
SEC:0000899243-21-020885:0 · 25 May 2021
€3m 135,000 shares @ €25.2508 26.6% of flow
Common Stock
SEC:0000899243-21-020885 · 25 May 2021
€4m 552,520 shares @ €6.5311 100.0% of flow
Common Stock
SEC:0000899243-21-020883 · 25 May 2021
€4m 552,520 shares @ €6.5311 50.0% of flow
Common Stock
SEC:0000899243-21-020883:0 · 25 May 2021
1,085,784 shares
Common Stock
SEC:0000899243-21-018932 · 6 May 2021
1,085,784 shares
Common Stock
SEC:0000899243-21-018932:0 · 6 May 2021
About Third Rock Ventures II, L.P. Third Rock Ventures II, L.P. is a director and insider, primarily involved with Revolution Medicines, Inc. and Jounce Therapeutics, Inc.